DLBCL, NOS “double expressor” seems to correlate with a worst prognosis, but the double expression of these two proteins is not necessarily a surrogate indicator of double translocation of c-MYC and BCL2 genes (“double-hit lymphomas”) [36, 37]. This evidence concerns the gene MYC and lymphoma.